Serodiagnosis of borreliosis: Indirect immunofluorescence assay, enzyme-linked immunosorbent assay and immunoblotting

Archivum Immunologiae et Therapiae Experimentalis

Volumn 59, Issue 1, 2011, Pages 69-77

  Wojciechowska Koszko, Iwona ^a   Ma̧cZyńska, Iwona ^a   Szych, Zbigniew ^a   Giedrys Kalemba, Stefania ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

ELISA; IIFA; Immunoblot; Lyme borreliosis; OspC protein; VlsE protein

Indexed keywords

BACTERIAL PROTEIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; OUTER SURFACE PROTEIN C ANTIGEN; UNCLASSIFIED DRUG; VARIABLE SURFACE RECOMBINANT ANTIGEN;

ARTICLE; BORRELIA AFZELII; BORRELIA BURGDORFERI; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; LYME DISEASE; NONHUMAN; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; BORRELIA BURGDORFERI; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOBLOTTING; LIPOPROTEINS; LYME DISEASE; POLAND; PREDICTIVE VALUE OF TESTS; SEROLOGIC TESTS;

EID: 79952532688     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-010-0111-0     Document Type: Article

References (19)

1. E Aberer 2007 Lyme borreliosis-an update J Dtsch Dermatol Ges 5 406 413 10.1111/j.1610-0387.2007.06285.x 17451386 (Pubitemid 46655950)
2. ME Aguero-Rosenfeld G Wang I Schwartz, et al. 2005 Diagnosis of lyme borreliosis Clin Microbiol Rev 18 484 509 1:CAS:528:DC%2BD2MXosVCjt7Y%3D 10.1128/CMR.18.3.484-509.2005 16020686 (Pubitemid 40995113)
3. ES Altpeter C Meier 1992 Epidemiologische Aspekte der Neurologischen Komplikationen der Lyme-Borreliose in der Schweiz Schweiz Med Wochenscher 122 22 26 1:STN:280:DyaK383nvFOhsg%3D%3D
4. E Cetin M Sotoudeh H Auer G Stanek 2006 Paradigm Burgenland: risk of Borrelia burgdoferi sensu lato infection indicated by variable seroprevalence rates in hunters Wien Klin Wochenschr 118 677 681 10.1007/s00508-006-0694-y 17160606 (Pubitemid 44953970)
5. J Chmielewska-Badora E Cisak A Wójcik-Fatla, et al. 2006 Correlation of tests for detection of Borrelia burgdorferi sensu lato infection in patients with diagnosed borreliosis Ann Agric Environ Med 13 307 311 1:CAS:528:DC%2BD2sXjsVKrtLo%3D 17196006 (Pubitemid 46074842)
6. M Figlerowicz 2006 Borelioza-pamia̧tka z wakacji Przew Lek 8 56 59
7. M Glatz V Fingerle B Wilske, et al. 2008 Immunoblot analysis of seroreactivity to recombinant Borrelia burgdorferi sensu lato antigens, including VlsE, in the long-term course of treated patients with erythema migrans Dermatology 216 93 103 1:CAS:528:DC%2BD1cXptlaqtQ%3D%3D 10.1159/000111505 18216470 (Pubitemid 351158572)
8. U Hauser G Lehnert R Lobentanzer B Wilske 1997 Interpretation criteria for standardized Western Blots for three European species of Borrelia burgdorferi sensu lato J Clin Microbiol 35 1433 1444 1:CAS:528: DyaK2sXjslyju7g%3D 9163458 (Pubitemid 27216809)
9. A Marangoni M Sparacino V Mondardini, et al. 2005 Comparative evaluation of two enzyme linked immunosorbent assay methods and three Western Blot methods for the diagnosis of culture-confirmed early Lyme Borreliosis in Italy New Microbiol 28 37 43 1:CAS:528:DC%2BD2MXjsV2rur8%3D 15782625 (Pubitemid 40342052)
10. J Niścigorska B Skotarczak B Wodecka 2003 Borrelia burgdorferi infection among forestry workers-assessed with an immunoenzymatic method (ELISA), PCR, and correlated with the clinical state of the patients Ann Agric Environ Med 10 15 19 12852729 (Pubitemid 36781776)
11. LH Sigal 1992 Current recommendations for the treatment of Lyme disease Drugs 43 683 699 1:STN:280:DyaK38zkslajsA%3D%3D 10.2165/00003495-199243050-00005 1379147
12. G Stanek F Strle 2009 Lyme borreliosis: a European perspective on diagnosis and clinical management Curr Opin Infect Dis 22 450 454 10.1097/QCO.0b013e32832ee880 19571749
13. AC Steere 1989 Lyme disease N Engl J Med 321 586 596 1:STN:280: DyaL1MzksVWkuw%3D%3D 10.1056/NEJM198908313210906 2668764 (Pubitemid 19212871)
14. S Tylewska-Wierzbanowska T Chmielewski 2005 Serological diagnosis of Lyme disease-European guidelines Postepy Mikrobiol 44 289 293 (Pubitemid 41680441)
15. B Wilske 2003 Diagnosis of Lyme borreliosis in Europe Vector Borne Zoonotic Dis 3 215 227 10.1089/153036603322662200 14733674
16. B Wilske V Fingerle P Herzer, et al. 1993 Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay Med Microbiol Immunol 182 255 270 1:STN:280:DyaK2c7htFKqug%3D%3D 10.1007/BF00579624 8283961 (Pubitemid 23327122)
17. B Wilske V Fingerle U Schulte-Spechtel 2007 Microbiological and serological diagnosis of Lyme borreliosis FEMS Immunol Med Microbiol 49 13 21 1:CAS:528:DC%2BD2sXhvVOit78%3D 10.1111/j.1574-695X.2006.00139.x 17266710 (Pubitemid 46160581)
18. J Zajkowska M Kondrusik S Pancewicz, et al. 2006 [Western-blot with VLSE protein and "in vivo" antigens in Lyme borreliosis diagnosis]. In Polish Przegl Epidemiol 60 suppl 1 177 185 16909799
19. JM Zajkowska M Kondrusik SA Pancewicz, et al. 2007 Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis Pol Merkur Lekarski 23 95 99 1:CAS:528:DC%2BD2sXht1yitLzE 18044336 in Polish